Therapy Areas: Infectious Diseases
Ondine Biomedical's Steriwave technology reduces surgical site infections by 71% in NHS deployment
2 April 2025 - Nasal photodisinfection system provider Ondine Biomedical Inc (LON: OBI) on Wednesday announced successful results from the first NHS deployment of its Steriwave nasal decolonisation te...
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
2 April 2025 - AKAGERA Medicines Inc, a biotech company developing novel lipid nanoparticle formulations of antibacterial drugs and mRNA vaccines to treat tuberculosis, avian flu, RSV and other infect...
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA
26 March 2025 - Clinical-stage life science company Vast Therapeutics announced on Tuesday that the US Food and Drug Administration has granted its ALX1 drug candidate 'Qualified Infectious Disea...
Ireland selects Conduent to enhance infectious disease management
20 March 2025 - Digital business solutions and services provider Conduent Incorporated (Nasdaq:CNDT) announced on Thursday that the Republic of Ireland's Health Service Executive (HSE) has select...
Pharming Group reports first patient dosed in Phase II trial of leniolisib for CVID with immune dysregulation
20 March 2025 - Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) announced on Thursday that the first patient has been dosed in a Phase II clinical trial evaluati...
bioMérieux receives FDA clearance for VITEK COMPACT PRO to combat antimicrobial resistance
18 March 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance for its VITEK COMPACT...